Stericycle (NASDAQ:SRCL) Now Covered by StockNews.com

StockNews.com started coverage on shares of Stericycle (NASDAQ:SRCL) in a research note published on Tuesday. The brokerage issued a hold rating on the business services provider’s stock.

Other analysts have also issued research reports about the company. Truist Financial raised their target price on Stericycle from $50.00 to $62.00 and gave the company a hold rating in a report on Tuesday, June 4th. Robert W. Baird lowered their price objective on shares of Stericycle from $62.00 to $55.00 and set a neutral rating on the stock in a research note on Friday, April 26th. Keefe, Bruyette & Woods boosted their target price on shares of Stericycle from $135.00 to $142.00 and gave the stock an outperform rating in a research report on Tuesday, June 4th. Finally, Royal Bank of Canada reissued a sector perform rating and issued a $62.00 price target (down from $69.00) on shares of Stericycle in a report on Tuesday, June 4th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of Hold and a consensus price target of $74.00.

Stericycle Stock Performance

Shares of NASDAQ SRCL opened at $58.50 on Tuesday. The business’s 50-day simple moving average is $56.36 and its 200-day simple moving average is $52.02. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.11 and a current ratio of 1.11. Stericycle has a 52 week low of $37.78 and a 52 week high of $59.45. The firm has a market cap of $5.43 billion, a price-to-earnings ratio of -265.91, a P/E/G ratio of 3.15 and a beta of 1.11.

Stericycle (NASDAQ:SRCL) last released its quarterly earnings results on Thursday, April 25th. The business services provider reported $0.57 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.54 by $0.03. The company had revenue of $664.90 million during the quarter, compared to analysts’ expectations of $676.42 million. Stericycle had a negative net margin of 0.74% and a positive return on equity of 7.31%. The business’s quarterly revenue was down 2.8% compared to the same quarter last year. During the same period in the prior year, the company earned $0.49 earnings per share. As a group, equities research analysts expect that Stericycle will post 2.32 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in SRCL. Skylands Capital LLC raised its holdings in shares of Stericycle by 28.8% in the 2nd quarter. Skylands Capital LLC now owns 29,100 shares of the business services provider’s stock worth $1,692,000 after buying an additional 6,500 shares in the last quarter. Summit Securities Group LLC acquired a new position in Stericycle during the second quarter worth $58,000. Blue Trust Inc. lifted its holdings in shares of Stericycle by 19.4% during the second quarter. Blue Trust Inc. now owns 4,936 shares of the business services provider’s stock valued at $287,000 after acquiring an additional 801 shares during the period. Wealth Enhancement Advisory Services LLC boosted its stake in shares of Stericycle by 6.4% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 7,447 shares of the business services provider’s stock valued at $433,000 after purchasing an additional 449 shares in the last quarter. Finally, SG Americas Securities LLC bought a new stake in shares of Stericycle in the 2nd quarter worth about $787,000. Institutional investors own 98.82% of the company’s stock.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.